BARCELONA, SPAIN — In the large Investigation of the Management of Pericarditis (IMPI) trial of patients with presumed tuberculous pericarditis, neither of two immunotherapies—prednisolone and ...

A 76-year-old woman with a history of childhood tuberculosis was examined before admission to a tuberculosis sanatorium. Over the past 4–5 years, she had been experiencing peripheral edema and ...

BARCELONA -- Adding steroids to anti-tuberculosis treatment for patients with tuberculous pericarditis can reduce the risk of an important complication and the resulting hospital admissions, ...

Researchers from South Africa and Canada have carried out a Cochrane review update to assess the safety and effectiveness of corticosteroids for treating tuberculous pericarditis. Tuberculosis (TB) ...

Researchers from South Africa and Canada have carried out a Cochrane review update to assess the safety and effectiveness of corticosteroids for treating tuberculous pericarditis. Tuberculosis (TB) ...

The disease usually starts as a fibrinous exudation with mycobacteria, polymorphonuclear cells and granuloma formation. The evolution is towards a serosanguineous exudate with lymphocytes, mononuclear ...

BARCELONA -- Adding steroids to anti-tuberculosis treatment for patients with tuberculous pericarditis can reduce the risk of complication and the resulting hospital admission, but adding prednisolone ...

Tuberculous pericarditis is associated with high mortality in parts of Africa and Asia, particularly in patients with concomitant HIV infection. Therefore, the IMPI trial (n = 1,400) was designed to ...

The scientists’ system can breach the heart’s protective membrane, a barrier that standard antibiotics cannot penetrate to be therapeutic. This breakthrough from the Wits Advanced Drug Delivery ...

A 76-year-old woman with a history of childhood tuberculosis was examined before admission to a tuberculosis sanatorium. Over the past 4–5 years, she had been experiencing peripheral edema and ...